ACLX
Price
$66.00
Change
-$0.51 (-0.77%)
Updated
Jun 13 closing price
Capitalization
3.64B
64 days until earnings call
MRUS
Price
$54.61
Change
-$0.78 (-1.41%)
Updated
Jun 13 closing price
Capitalization
4.07B
46 days until earnings call
Interact to see
Advertisement

ACLX vs MRUS

Header iconACLX vs MRUS Comparison
Open Charts ACLX vs MRUSBanner chart's image
Arcellx
Price$66.00
Change-$0.51 (-0.77%)
Volume$514.54K
Capitalization3.64B
Merus
Price$54.61
Change-$0.78 (-1.41%)
Volume$711.65K
Capitalization4.07B
ACLX vs MRUS Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. MRUS commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Buy and MRUS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (ACLX: $66.00 vs. MRUS: $54.61)
Brand notoriety: ACLX and MRUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 67% vs. MRUS: 55%
Market capitalization -- ACLX: $3.64B vs. MRUS: $4.07B
ACLX [@Biotechnology] is valued at $3.64B. MRUS’s [@Biotechnology] market capitalization is $4.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileMRUS’s FA Score has 1 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • MRUS’s FA Score: 1 green, 4 red.
According to our system of comparison, MRUS is a better buy in the long-term than ACLX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 6 TA indicator(s) are bullish while MRUS’s TA Score has 5 bullish TA indicator(s).

  • ACLX’s TA Score: 6 bullish, 2 bearish.
  • MRUS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than MRUS.

Price Growth

ACLX (@Biotechnology) experienced а -3.08% price change this week, while MRUS (@Biotechnology) price change was -2.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

ACLX is expected to report earnings on Aug 18, 2025.

MRUS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRUS($4.07B) has a higher market cap than ACLX($3.64B). MRUS YTD gains are higher at: 29.869 vs. ACLX (-13.939). ACLX has higher annual earnings (EBITDA): -153.96M vs. MRUS (-298.55M). ACLX has more cash in the bank: 543M vs. MRUS (458M). MRUS has less debt than ACLX: MRUS (9.86M) vs ACLX (53.2M). ACLX has higher revenues than MRUS: ACLX (76.8M) vs MRUS (54.7M).
ACLXMRUSACLX / MRUS
Capitalization3.64B4.07B89%
EBITDA-153.96M-298.55M52%
Gain YTD-13.93929.869-47%
P/E RatioN/AN/A-
Revenue76.8M54.7M140%
Total Cash543M458M119%
Total Debt53.2M9.86M540%
FUNDAMENTALS RATINGS
MRUS: Fundamental Ratings
MRUS
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
25
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXMRUS
RSI
ODDS (%)
Bullish Trend 6 days ago
90%
Bearish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
74%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
87%
Bullish Trend 13 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
79%
Bearish Trend 11 days ago
80%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMBFX35.61-0.31
-0.86%
American Funds American Balanced F2
ELFNX89.13-1.25
-1.38%
Elfun Trusts
JABVX10.33-0.16
-1.53%
JHancock Global Environmental Opps I
NIQVX14.74-0.24
-1.60%
Neuberger Berman International Eq Inv
ZGFAX19.39-0.33
-1.67%
American Beacon Ninety One Gbl Frnchs Y

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with CGON. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-0.77%
CGON - ACLX
57%
Loosely correlated
-2.42%
KRYS - ACLX
56%
Loosely correlated
-2.32%
RNA - ACLX
55%
Loosely correlated
-2.40%
BEAM - ACLX
53%
Loosely correlated
-2.18%
XNCR - ACLX
53%
Loosely correlated
-2.55%
More

MRUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRUS has been loosely correlated with VIGL. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if MRUS jumps, then VIGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRUS
1D Price
Change %
MRUS100%
-1.41%
VIGL - MRUS
49%
Loosely correlated
-0.13%
IDYA - MRUS
48%
Loosely correlated
-0.45%
CGON - MRUS
48%
Loosely correlated
-2.42%
ACLX - MRUS
47%
Loosely correlated
-0.77%
RVMD - MRUS
46%
Loosely correlated
-1.26%
More